• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Hedge fund billionaire puts more skin in med-tech | Funding Roundup

Hedge fund billionaire puts more skin in med-tech | Funding Roundup

June 3, 2011 By MassDevice staff

Funding

Mario Gabelli, one of the world’s wealthiest men, put another $3.4 million into Orthovita Inc. (NSDQ:VITA) and dropped $25 million on American Medical Systems Holdings Inc. (NSDQ:AMMD).

Both companies are in the middle of mergers. Orthovita received a $3.85-per-share tender offer from Stryker Corp. (NYSE:SYK) last week; AMMD announced a $2.9 billion acquisition by Endo Pharmaceuticals Holdings Inc. (NSDQ:ENDP) in April.

Gabelli is chairman & CEO of Gamco Investors Inc. (NYSE:GBL), a $14 billion global investment firm based in Rye, N.Y. He’s No. 937 on the Forbes 2010 list of the world’s billionaires.

"We like to buy companies that are ignored and unloved," Gabelli told Bloomberg Television, talking about Gamco’s investment philosophy.

The investment tycoon first unveiled a 5.42 percent stake in Orthovita just days before the announcement of Stryker’s tender offer. The new stock brings Gabelli’s total investment in the Malvern, Pa.-based orthopedic biologics maker to nearly $18.5 million, with 6.58 percent ownership, according to the filing.

Gabelli’s $24 million bought him 6.46 percent of AMMD, which reported modest gains in its first quarter 2011 earnings report.

Gamco had no stake in either company as of its first-quarter holdings report.

Here’s a roundup of other dealflow and investment news:

  • CSI files $75 million equity and debt offering
    Cardiovascular Systems Inc. (NSDQ:CSII) registered with the federal SEC to sell up to $75 million in equity and debt securities. The New Brighton, Minn.-based cardiovascular device maker hasn’t announced plans to release the securities into the market.
    Read more
  • Lumicell lands $2.7 million
    Lumicell Diagnostics Inc., a Waltham, Mass.-based developer of cancer diagnostic devices, announced a $2.7 million equity sale to 4 unnamed investors. The company hopes to rein in another $1.2 million in this round.
    Read more

Filed Under: News Well Tagged With: American Medical Systems Holdings Inc., Cardiovascular Systems Inc., Gamco Investors Inc., Lumicell, Orthovita Inc., Stryker, Venture Capital/Private Equity

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy